• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 3. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives

Comprehensive Overview of 6-Hydroxy-1-methyl-2,3-dihydroindole-5-carbaldehyde (CAS No. 1515517-77-7): Properties, Applications, and Research Insights

6-Hydroxy-1-methyl-2,3-dihydroindole-5-carbaldehyde (CAS No. 1515517-77-7) is a specialized organic compound belonging to the indole derivative family. With its unique molecular structure featuring a hydroxy group, methyl substitution, and an aldehyde functionality, this compound has garnered significant attention in pharmaceutical and material science research. The indole core is known for its prevalence in bioactive molecules, making this aldehyde derivative particularly intriguing for drug discovery and development.

Recent studies highlight the growing interest in indole-based aldehydes due to their potential as intermediates in synthesizing complex heterocyclic systems. Researchers are actively exploring 6-Hydroxy-1-methyl-2,3-dihydroindole-5-carbaldehyde for its possible role in creating novel antioxidant agents and neuroprotective compounds, aligning with current trends in neurodegenerative disease research. The compound's electron-rich aromatic system and reactive aldehyde group make it a versatile building block in medicinal chemistry.

From a synthetic chemistry perspective, the 1515517-77-7 compound offers multiple sites for chemical modification. The 5-carbaldehyde group can participate in condensation reactions, while the 6-hydroxy moiety provides opportunities for etherification or esterification. These characteristics have led to increased patent activity surrounding dihydroindole derivatives, particularly in areas addressing oxidative stress-related conditions.

Analytical characterization of 6-Hydroxy-1-methyl-2,3-dihydroindole-5-carbaldehyde typically involves advanced techniques such as HPLC-MS and NMR spectroscopy. The compound's stability profile shows optimal performance under controlled conditions, with recommended storage in amber vials at low temperatures to preserve its aldehyde functionality. These handling protocols are crucial for researchers working with this sensitive intermediate.

In material science applications, the indole-carbaldehyde hybrid structure has shown promise in developing organic semiconductors and photoactive materials. The compound's ability to form stable charge-transfer complexes makes it interesting for optoelectronic device research, particularly in the context of sustainable energy solutions. This aligns with current market demands for eco-friendly electronic materials.

Quality control specifications for CAS 1515517-77-7 typically require ≥95% purity by HPLC analysis, with strict limits on residual solvents. The compound's synthesis often involves multi-step procedures starting from commercially available indole precursors, with careful optimization required to maximize yield while maintaining the integrity of its sensitive functional groups.

Recent literature surveys indicate growing interest in the biological activity screening of 6-Hydroxy-1-methyl-2,3-dihydroindole-5-carbaldehyde derivatives. Preliminary studies suggest potential interactions with various enzymatic systems, though comprehensive pharmacological evaluations are still ongoing. The scientific community particularly notes its structural similarity to certain natural product scaffolds found in marine organisms and plants.

From a regulatory standpoint, 1515517-77-7 is currently classified as a research chemical with no reported commercial drug applications. However, its structural features continue to attract attention in fragment-based drug design approaches. The compound's molecular weight (191.19 g/mol) and lipophilicity parameters make it suitable for lead optimization programs in central nervous system targeting agents.

Environmental and safety assessments of 6-Hydroxy-1-methyl-2,3-dihydroindole-5-carbaldehyde suggest standard laboratory handling precautions are sufficient. The compound shows moderate water solubility but may require organic cosolvents for biological testing. These physicochemical properties are carefully considered in modern ADMET prediction models during early-stage drug discovery.

The future research directions for CAS No. 1515517-77-7 appear promising, with several academic and industrial groups investigating its potential in multi-target therapeutics and smart material development. As synthetic methodologies advance, we anticipate seeing more sophisticated derivatives of this dihydroindole carbaldehyde scaffold entering preclinical evaluation pipelines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)